NUVA News and Press, NuVasive Inc. From 02/22/23

NuVasive press release ( NASDAQ: NUVA ): Q4 Non-GAAP EPS of $0.43 misses by $0.08 . Revenue of $305.4M (+1.1% Y/Y) misses by $5.61M . The Company expects 2023 net sales growth of 6%ꟷ8% on an as reported and constant currency basis vs. 5.57% consensus ...

NuVasive Announces Fourth Quarter and Full-Year 2022 Financial Results and 2023 Net Sales Guidance PR Newswire – Full-year 2022 net sales grew 5.5% as reported, 8.5% on a constant currency basis – – Continued strong international growth in 2022 &...

NuVasive Enhances C360 Portfolio with Expanded Indications for Modulus Cervical and Attrax Putty PR Newswire Attrax Putty is now on-label for use with cervical Modulus interbody implants SAN DIEGO , Feb. 21, 2023 /PRNewswire/ -- NuVasive, Inc. (NASDA...

NEW YORK, NY / ACCESSWIRE / February 14, 2023 / Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: Cardiovascular Systems, Inc. (NAS...

Summary Globus Medical announced a merger with NuVasive on 8th February. The merger will create the second-largest spine business behind Medtronic, with 21% of the global market share. Analysts expressed doubts about the potential benefits of this merger, lowered their Buy ratings t...

Summary Globus Medical has been a long-term secular growth player in the spine industry. The company has seen solid growth, but surprised investors with a +$3 billion deal for NuVasive for which it has seen a terrible reception despite anticipated cost synergies. I believe that the ...

Summary Globus and NuVasive agreed to merge in a deal that will see Globus acquire its spinal surgery rival for 0.75 shares of GMED per NUVA share (or $3.1B). Globus shares sold off sharply, as the Street clearly isn't sold on the advantages of the deal and/or Globus management's abilit...

MONSEY, N.Y., Feb. 09, 2023 (GLOBE NEWSWIRE) -- The law firm of Wohl & Fruchter LLP is investigating whether the directors of NuVasive, Inc. (Nasdaq: NUVA) (“NuVasive”) acted in the best interests of NuVasive shareholders in approving the merger of NuVasive with Globus Medical, ...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Source: Eric Urquhart/Shutterstock.com We’re starting off another day of trading with a look at the biggest pre-market stock movers for Wednesday! Moving stocks this morning are earnings reports, public stock off...

Medical device makers NuVasive ( NASDAQ: NUVA ) and Globus Medical ( NYSE: GMED ) announced an agreement on Thursday to combine in an all-stock transaction giving NuVasive ( NUVA ) an equity value of more than $3B. Shares of both companies are currently on hold. Per the te...